Interactions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas

The present study addressed links between progestin and heregulin (HRG) signaling pathways in mammary tumors. An experimental model of hormonal carcinogenesis, in which the synthetic progestin medroxyprogesterone acetate (MPA) induced mammary adenocarcinomas in female Balb/c mice, was used. MPA indu...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Balañá, M.E., Lupu, R., Labriola, L., Charreau, E.H., Elizalde, P.V.
Formato:	JOUR
Materias:	Heregulin Mouse mammary tumors Progestin Type I insulin-like growth factor receptor antisense oligodeoxynucleotide gestagen medroxyprogesterone acetate messenger RNA neu differentiation factor somatomedin C somatomedin C receptor animal cell animal experiment article breast adenocarcinoma cell growth cell proliferation controlled study epithelium cell female hormonal carcinogenesis mitogenesis mouse nonhuman phenotype priority journal protein phosphorylation signal transduction Animalia
Acceso en línea:	http://hdl.handle.net/20.500.12110/paper_09509232_v18_n46_p6370_Balana
Aporte de:	Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) de Universidad de Buenos Aires

Ejemplares similares

Interactions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas
Publicado: (1999)

Involvement of insulin-like growth factors-I and-II and their receptors in medroxyprogesterone acetate-induced growth of mouse mammary adenocarcinomas
por: Elizalde, P.V., et al.

Involvement of insulin-like growth factors-I and-II and their receptors in medroxyprogesterone acetate-induced growth of mouse mammary adenocarcinomas
Publicado: (1998)

Factores de crecimiento y oncogenes en adenocarcinomas mamarios inducidos por acetato de medroxyprogesterona en ratones BALB/c
por: Elizalde, P.V., et al.

Mechanisms of cell cycle arrest in response to TGF-β in progestin- dependent and -independent growth of mammary tumors
Publicado: (2001)

Mechanisms of cell cycle arrest in response to TGF-β in progestin- dependent and -independent growth of mammary tumors
por: Salatino, M., et al.

Factores de crecimiento y oncogenes en adenocarcinomas mamarios inducidos por acetato de medroxyprogesterona en ratones BALB/c
Publicado: (1997)

Activation of Stat3 by heregulin/ErbB-2 through the co-option of progesterone receptor signaling drives breast cancer growth
Publicado: (2009)

Activation of Stat3 by heregulin/ErbB-2 through the co-option of progesterone receptor signaling drives breast cancer growth
por: Proietti, C.J., et al.

Changes in IGF-I receptor and IGF-I mRNA during differentiation of 3T3-L1 preadipocytes
por: Zizola, C.F., et al.

Insulin-like growth factor-I production and receptors in mammary adenocarcinomas induced by medroxyprogesterone acetate in BALB/c mice
Publicado: (1990)

Insulin-like growth factor-I production and receptors in mammary adenocarcinomas induced by medroxyprogesterone acetate in BALB/c mice
por: Elizalde, P.V., et al.

Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insalia-like growth factor receptor in mammary tumor cells
por: Labriola, Leticia, et al.
Publicado: (2001)

Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insalia-like growth factor receptor in mammary tumor cells
por: Balãá, M.E., et al.
Publicado: (2001)

Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insalia-like growth factor receptor in mammary tumor cells
por: Balãá, M.E., et al.

Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insalia-like growth factor receptor in mammary tumor cells
por: Balãá, M.E., et al.
Publicado: (2001)

Changes in IGF-I receptor and IGF-I mRNA during differentiation of 3T3-L1 preadipocytes
Publicado: (2002)

Type I insulin-like growth factor receptor antisense strategies in experimental breast cancer
Publicado: (2004)

Type I insulin-like growth factor receptor antisense strategies in experimental breast cancer
por: Salatino, M., et al.

The role of estrogen receptor alpha in breast cancer cell proliferation mediated by progestins
Publicado: (2012)

The role of estrogen receptor alpha in breast cancer cell proliferation mediated by progestins
por: Lanari, C., et al.

ErbB2 and EGFR are downmodulated during the differentiation of 3T3-L1 preadipocytes
por: Pagano, Eleonora, et al.
Publicado: (2003)

ErbB2 and EGFR are downmodulated during the differentiation of 3T3-L1 preadipocytes
por: Pagano, E., et al.

Varying patterns of expression of insulin-like growth factors I and II and their receptors in murine mammary adenocarcinomas of different metastasizing ability
Publicado: (1996)

Varying patterns of expression of insulin-like growth factors I and II and their receptors in murine mammary adenocarcinomas of different metastasizing ability
por: Guerra, F.K., et al.

Progestin-induced caveolin-1 expression mediates breast cancer cell proliferation
Publicado: (2006)

Progestin-induced caveolin-1 expression mediates breast cancer cell proliferation
por: Salatino, M., et al.

Comparative studies between freshly isolated and spontaneously immortalized bovine granulosa cells: Protein secretion, steroid metabolism, and responsiveness to growth factors
por: Colman Lerner, Alejandro Ariel, et al.
Publicado: (1995)

Comparative studies between freshly isolated and spontaneously immortalized bovine granulosa cells: Protein secretion, steroid metabolism, and responsiveness to growth factors
por: Colman Lerner, A.A., et al.

Insulin-like growth factor-1 increases the mitogenic response of human peripheral blood lymphocytes to phytohemagglutinin
Publicado: (1989)

Insulin-like growth factor-1 increases the mitogenic response of human peripheral blood lymphocytes to phytohemagglutinin
por: Roldan, A., et al.

Role of receptors for epidermal growth factor and insulin-like growth factors I and II in the differentiation of rat mammary glands from lactogenesis I to lactogenesis II
Publicado: (1996)

Role of receptors for epidermal growth factor and insulin-like growth factors I and II in the differentiation of rat mammary glands from lactogenesis I to lactogenesis II
por: Bussmann, L.E., et al.

Heregulin inhibits proliferation via ERKs and phosphatidyl-inositol 3-kinase activation but regulates urokinase plasminogen activator independently of these pathways in metastatic mammary tumor cells
por: Puricelli, L., et al.
Publicado: (2002)

Heregulin inhibits proliferation via ERKs and phosphatidyl-inositol 3-kinase activation but regulates urokinase plasminogen activator independently of these pathways in metastatic mammary tumor cells
por: Puricelli, L., et al.

Heregulin inhibits proliferation via ERKs and phosphatidyl-inositol 3-kinase activation but regulates urokinase plasminogen activator independently of these pathways in metastatic mammary tumor cells
por: Puricelli, L., et al.
Publicado: (2002)

Heregulin inhibits proliferation via ERKs and phosphatidyl-inositol 3-kinase activation but regulates urokinase plasminogen activator independently of these pathways in metastatic mammary tumor cells
por: Puricelli, Lydia Inés, et al.
Publicado: (2002)

Disruption of the D2 dopamine receptor alters GH and IGF-I secretion and causes dwarfism in male mice
Publicado: (2002)

Disruption of the D2 dopamine receptor alters GH and IGF-I secretion and causes dwarfism in male mice
por: Díaz-Torga, G., et al.

Expression of erythroblastic leukemia viral oncogene homolog (erbBS) mRNAs and possible splice variants in 3T3-L1 preadipocytes
Publicado: (2011)